![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 47, 36632-36636, November 24, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, January 28, 2000, and in revised form, August 10, 2000
Although [Cl In epithelia, both [Cl We have previously shown that
[Cl In this study, our objective was to establish the identity of the
ion-sensitive phosphoprotein p37 and to characterize its phosphorylated
amino acid residue. By selectively enhancing phosphorylation of p37 (3)
and by applying metal affinity chromatography, we show that p37 is
identical to annexin I and provide evidence for novel annexin
phosphorylation on histidine residues. Our data suggest that annexin is
a component of an intracellular signaling system involving histidine
phosphorylation, which is regulated by chloride concentration.
Sample Preparation--
A membrane fraction was prepared from
ovine airway epithelia as described previously (3). Briefly, tracheal
epithelia were scraped and dislodged into homogenization buffer (250 mM sucrose, 10 mM triethanolamine; one protease
inhibitor tablet from Roche Molecular Biochemicals per 50 ml
buffer). Pooled scrapings were homogenized and spun at 600 × g for 15 min. The post-nuclear supernatant was re-spun at
100,000 × g for 2 h. The pellet was resuspended in homogenization buffer and spun for 30 min at 16,000 × g (this procedure was repeated three times). All procedures
were conducted at 4 °C. Use of lactate dehydrogenase as a cytosol
marker showed that the pellet contained no cytosol (3). Aliquots of the
cytosol and membrane pellet were stored in liquid nitrogen.
Phosphorylation and Electronic
Autoradiography--
Phosphorylation and detection of phosphoproteins
were performed as described previously (3). Briefly, proteins were
phosphorylated with 37 kBq of [ Western Blotting--
Proteins (10 µg), separated by
SDS-polyacrylamide gel electrophoresis, were transferred to
polyvinylidene difluoride membrane (Millipore Corp.) by semidry
electrophoretic transfer (Amersham Pharmacia Biotech) at 0.8 mA/cm2 for 1 h with 20% methanol added to standard
SDS-polyacrylamide gel electrophoresis running buffer. Prestained
markers were used to confirm transfer. The primary antibody (1:2000)
was an affinity-purified rabbit polyclonal antibody directed against a
carboxyl-terminal peptide of annexin I (epitope corresponding to amino
acids 324-342; Santa Cruz Biotechnology). A horseradish
peroxidase-conjugated anti-rabbit secondary antibody (Scottish Antibody
Production Unit) and ECL detection (Amersham Pharmacia Biotech) were
used to locate annexin I.
Immunoprecipitation--
Membranes were resuspended in 100 µl
of 10 mM MOPS (pH 7.9) and phosphorylated with 67 nM [ Purification of Annexin I--
The membrane fraction from sheep
tracheal epithelia was solubilized with 0.25% glucopyranoside in 10 mM Tris-HCl (pH 7.4) containing a mixture of protease
inhibitors (CompleteTM protease inhibitor tablets, Roche
Molecular Biochemical) and then centrifuged at 100,000 × g for 30 min at 4 °C. The supernatant fraction (100 ml,
1434 mg of protein) was incubated for 5 min at 37 °C with 50 nM ATP and 500 nM GDP to enhance
phosphorylation of the 37-kDa protein 20-fold as described previously
(3). Following incubation, the temperature and pH of the sample (100 ml) were simultaneously adjusted to 4 °C and 5.0, respectively, by
adding 400 ml of buffer A (0.1 M acetic acid/NaOH (pH 5.0), 0.5 M NaCl, 0.4 mM
4-(2-aminoethyl)benzenesulfonyl fluoride, and 0.1% glucopyranoside).
The sample (500 ml) was then applied to a chelating Sepharose fast flow
column (50 ml) charged with ferric chloride and pre-equilibrated with
buffer A. The column was washed with buffer A (15 column
volumes/stable A280 ~ 0.01), and the bound
phosphoproteins were selectively eluted with 20 mM sodium biphosphate in buffer A. The eluate (100 ml, 1.13 mg) was dialyzed against buffer B (20 mM Tris-HCl (pH 8.5) and 0.1%
glucopyranoside) and applied to a strong anion exchange column (POROS
HQ 20, 1 ml) pre-equilibrated with the same buffer. Elution from the
ion exchange column was carried out with a linear gradient of 0-1 M NaCl in buffer B.
On discovering that p37 was identical to annexin I, we modified the
purification procedure and included a Ca2+-chelating agent
to extract membrane-associated calcium-binding proteins. The membrane
fraction was incubated with 10 mM Tris-HCl (pH 7.4)
containing 5 mM BAPTA for 30 min on ice. Following
centrifugation, the supernatant was phosphorylated with unlabeled
ATP/GDP and applied to a chelating Fe3+-Sepharose column as
described above.
Protein Sequence Analysis--
N-terminal sequencing and in-gel
tryptic peptide digests of the purified proteins were conducted
according to published procedures (7).
Phosphoamino Acid Analysis--
To determine the nature of the
phosphate linkage on [32P]annexin I, a membrane fraction
was labeled with [
The precise phosphorylated residue was determined by HPLC phosphoamino
acid analysis as described previously (9). Briefly, proteins were
phosphorylated and blotted onto polyvinylidene difluoride as described
above. The phosphorylated bands were excised, digested under alkaline
conditions, and analyzed in the presence of phosphoamino acid standards
by anion exchange HPLC coupled with fluorescence detection. Fractions
were collected, and radioactivity was detected by Cerenkov counting.
Purification and Characterization of p37--
Phosphoproteins and
phosphopeptides are known to bind to immobilized iminodiacetic acid
when charged with ferric chloride (10). Because p37 is the only major
phosphorylated protein when membrane proteins from ovine airway
epithelia are incubated with ATP and GDP (3), we used metal chelate
(iminodiacetic acid-Fe3+) affinity chromatography (10) to
isolate phosphorylated p37. The eluate from the chelating Sepharose
column was further purified by anion exchange chromatography (POROS HQ
20). More than 95% of the protein (A280)
applied was found in the anion exchange column flow-through fraction.
SDS-polyacrylamide gel electrophoresis analysis of this fraction
(Coomassie Blue staining) showed a major band of 37 kDa and two minor
bands of 70 and 80 kDa (Fig.
1a). Microsequence analysis of
the purified products using in-gel peptide digestion and N-terminal
sequencing showed that all three bands had 100% homology to bovine
annexin I (Fig. 1b). Two of the sequences obtained related
to the N-terminal domain of annexin I, which is unique to annexin I. Immunoprecipitation of phosphorylated ovine p37 with annexin I-specific
antibodies provided additional proof that p37 and annexin I were
identical (Fig. 1c).
To test whether annexin I possessed intrinsic protein kinase activity,
purified annexin I was incubated with [ Phosphoamino Acid Analysis--
Annexin I is phosphorylated on
serine and tyrosine residues within the N-terminal domain by protein
kinase C and epidermal growth factor receptor kinase, respectively
(11). However, the identity of p37 as annexin I was intriguing
particularly because general and specific inhibitors of protein kinase
C, tyrosine kinase, casein kinase II, and PKA failed to inhibit its
phosphorylation (data not shown) (4). We had also observed loss of
label from p37 on SDS gels destained with acetic acid-containing
destaining solutions. In addition, phosphoamino acid analysis
procedures that included acid hydrolysis (6 N HCl for
2 h at 105 °C) of phosphoannexin I (labeled with
[ Localization of Phosphohistidine on Annexin I--
To further
characterize annexin I phosphorylation, a BAPTA extract partially
purified on a chelating Fe3+-Sepharose column was
phosphorylated with [ Regulation of Phosphorylation by cAMP--
While characterizing
another chloride-sensitive phosphoprotein, nucleoside-diphosphate
kinase (a multifunctional protein-histidine kinase), we observed
inhibition of p37 phosphorylation by cAMP. Interestingly, cAMP has been
shown to bind to annexin I and to abolish its ability to act as a
calcium channel in artificial lipid bilayers (11). Following
preincubation with N6-Bt-cAMP (0-1
mM) for 30 min at 4 °C, a membrane preparation was phosphorylated with [ The transfer of a reactive phosphoryl group from phosphorylated
histidine kinase to an acceptor is a primary step in many cellular
signaling responses. For example, in bacteria, yeast, and higher
plants, phosphorylation of histidine is the first step in substrate
sensory cascades such as the two-component phosphorylation systems (for
reviews, see Refs. 8 and 12-14). In mammals, phosphohistidine has
previously been identified on the C terminus of P-selectin from
activated platelet cells (15) and on G protein The failure of annexin I to autophosphorylate when incubated with
nucleotides indicates that it is a substrate for a distinct histidine
protein kinase whose activity is predicted to be regulated by chloride
and other ions (3, 4). Interestingly, annexins share sequence homology
with a cAMP-activated chloride channel, the cystic fibrosis
transmembrane regulator, in the region of its common mutation
Phe508 (17) and, among other functions, appear to regulate
secretion and ion transport by unknown mechanisms. Annexins II and IV
have been shown to modulate various chloride channel activities in epithelial and endothelial cells (18-21).
Structurally, annexins share a conserved series of 70-amino acid
repeats organized into a core structure that binds reversibly to acidic
phospholipids and cellular membranes in a calcium-dependent manner. Each annexin also contains an amino-terminal segment that is
unique to each protein and that varies in sequence and length (for
reviews, see Refs. 22-25). Although the repeat units of the core
domain contain both the Ca2+- and phospholipid
(membrane)-interactive elements of the protein, the N-terminal domain
regulates both the binding affinities for phospholipids and the
subcellular localization (26) and is thus thought to provide functional
specificity for individual annexins. Moreover, regulation via the
N-terminal domain occurs through several post-translational
modifications within the N-terminal sequences of some annexins and
includes phosphorylation (27), transglutamination (28), proteolytic
cleavage (29), and attachment to other proteins (30, 31). The above
modifications influence the annexin-induced aggregation of phospholipid
vesicles and chromaffin granules, together with the calcium requirement
for these reactions (32-36). In addition, they control the interaction
with some S100 calcium-binding proteins (34-36). The cellular
consequences of these regulatory events remain to be established.
The generation of a phosphorylated fragment whose sequence corresponds
to the C-terminal half of annexin I localizes the site of histidine
phosphorylation to the core. To our knowledge, this is only the second
report showing phosphorylation of an annexin core. In vitro
phosphorylation of annexin I at threonine 216 by PKA has been reported
(37), but its physiological significance is controversial. Thus,
phosphorylation may regulate annexin I function via both the N-terminal
and core domains. Notably, all the histidine residues of annexin I lie
within the Ca2+-dependent phospholipid-binding
core and, with one exception, are located on the face of the molecule
that interacts with phospholipids (38). The proposed functions of the
core, which include membrane organization and aggregation (39, 40), may
be affected by phosphorylation-induced charge alterations on histidine.
Consistent with this notion, maximal changes in histidine ionization
occur within the physiological range of intracellular pH. In addition, cAMP binds annexin I via a proposed cAMP-binding site, adjacent to a
conserved histidine (His103), and profoundly alters both
the membrane aggregating and calcium channel properties of annexin I in
lipid bilayers (11). Our observed inhibition of histidine
phosphorylation of annexin I by N6-Bt-cAMP and
AMP could result from an altered conformation such that the histidine
residue(s) become inaccessible to the kinase. Alternatively, AMP may
also bind to the histidine kinase and allosterically regulate its
activity or compete with ATP for the active site. The inhibition by AMP
is not observed with IMP or
CMP,2 indicating specificity
for the adenosine moiety. cAMP binding and the resulting alteration of
the conformation of intracellular effector molecules such as PKA are
thought to be the basis of most of the cAMP effects on cellular
function (41). The cAMP signal is then subsequently inactivated and
terminated by phosphodiesterases whose activity may be regulated by PKA
in a feedback loop (42, 43). Although a number of phosphodiesterases
exist in airway epithelia (44), our results suggest that PKA and
phosphodiesterase activities do not directly influence the effects of
cAMP on annexin I phosphorylation. Thus, cAMP may either act through a
hitherto unknown pathway or bind directly to the histidine kinase and
allosterically regulate its activity. The enhanced annexin I
phosphorylation observed with both stereoisomers of cAMP indicates
that, unlike PKA, the histidine kinase fails to distinguish between
(Rp)- and (Sp)-cAMP-S;
thus, cAMP-binding site(s) on the histidine kinase may be different
from those on PKA. The failure of cGMP to influence annexin I
phosphorylation suggests that there is no cross-activation between the
two cyclic nucleotides.
Phosphorylation within the core domain, which is highly conserved among
annexins, suggests that histidine phosphorylation may also be a feature
of other members of the annexin family. Considering the limited number
of post-translational modifications that occur within the N-terminal
domains of annexins and the diversity of processes in which annexin
function has been suggested, it is possible that other
post-translational modifications of the core exist. Clearly,
modification of the core domain by phosphorylation suggests that
phosphatase(s) and other proteins may interact with this domain to
modulate the histidine phosphorylation signal. Proteolytic cleavage of
annexin I within its N-terminal domain is well documented (although the
protease responsible is not known) and has been shown to modulate
annexin function (29, 45). Susceptibility to proteolytic cleavage of
the N-terminal "tail" is increased following phosphorylation on
Tyr21 by the epidermal growth factor receptor kinase (46,
47). In contrast, the core has previously been regarded to be highly resistant to proteolytic cleavage. The cleavage of
[32P]annexin I within the core to generate a
phosphorylated C-terminal fragment requires further investigation, as
it is presently unclear whether or not its cleavage is induced by
phosphorylation. A similarly sized fragment from annexin I has been
reported previously in samples from cells labeled with phosphate (48).
It is possible that phosphohistidine may initiate annexin I cleavage
and thus generate active peptide fragments or lead to further
degradation of the protein.
We thank Tuongdieu Quach (Kristy) for
technical assistance and Dr. Andy Chronshaw (Welmet Protein
Characterization Facility, University of Edinburgh) for protein sequencing.
*
This work was supported by Wellcome Trust Grant
0044854/Z/95/A, by Biomed II Network Grant BM H4-CT96-0602, and by
grants from the Cystic Fibrosis Trust, Tenovus Tayside, the
Deutsche Forschungsgemeinschaft, the Royal Society, and the Anonymous
Trust.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 44-1382-660111 (ext. 33055); Fax: 44-1382-632597; E-mail: r.muimo@dundee.ac.uk.
Published, JBC Papers in Press, August 23, 2000, DOI 10.1074/jbc.M000829200
2
R. Muimo, unpublished data.
The abbreviations used are:
MOPS, 4-morpholinepropanesulfonic acid;
BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid;
HPLC, high pressure liquid chromatography;
PKA, protein
kinase A;
Bt-cAMP, monobutyryladenosine 3':5'-monophosphate;
Bt2cAMP, dibutyryladenosine 3':5'-monophosphate;
cAMP-S, adenosine 3':5'- monophosphorothioate.
Histidine Phosphorylation of Annexin I in Airway Epithelia*
§,
,
,
, and
Tayside Institute of Child Health, Ninewells
Hospital and Medical School, University of Dundee, Dundee DD1 9SY,
United Kingdom, the
Department of Biological Chemistry,
University of California, Davis, California 95616, and the
¶ Institue of Medical Biochemistry, University of Münster,
von-Esmarch-Strasse 56, D-48149 Münster, Federal Republic Germany
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
]i
regulates many cellular functions including cell secretion, the
mechanisms governing these actions are not known. We have
previously shown that the apical membrane of airway epithelium
contains a 37-kDa phosphoprotein (p37) whose phosphorylation is
regulated by chloride concentration. Using metal affinity (chelating
Fe3+-Sepharose) and anion exchange (POROS HQ 20)
chromatography, we have purified p37 from ovine tracheal epithelia to
electrophoretic homogeneity. Sequence analysis and immunoprecipitation
using monoclonal and specific polyclonal antibodies identified p37 as
annexin I, a member of a family of
Ca2+-dependent phospholipid-binding proteins.
Phosphate on [32P]annexin I, phosphorylated using both
[
-32P]ATP and [
-32P]GTP, was labile
under acidic but not alkaline conditions. Phosphoamino acid analysis
showed the presence of phosphohistidine. The site of phosphorylation
was localized to a carboxyl-terminal fragment of annexin I. Our data
suggest that cAMP and AMP (but not cGMP) may regulate annexin I
histidine phosphorylation. We propose a role for annexin I in an
intracellular signaling system involving histidine phosphorylation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
]i and cell volume
are tightly regulated during fluid secretion and/or absorption (1).
Epithelia transport many times their own cellular mass of chloride and
other ions, but it is unclear how cells sense
[Cl
]i. It is known that
[Na+]i and [Cl
]i
interact in cell volume regulation (2). The multiple cellular functions
regulated by [Cl
]i (cystic fibrosis
transmembrane regulator channel conductance, epithelial sodium
channels, cell volume,
Na+K+2Cl-cotransporter activity, etc.)
argue for a common regulatory pathway.
]/[anions]/ATP/GTP differentially determine
the profile of phosphorylation of a number of apical membrane proteins
in airway epithelia (3, 4). We identified two of the phosphoproteins, a
19/21-kDa doublet that showed chloride
concentration-dependent phosphorylation, as two isoforms of
nucleoside-diphosphate kinase (3, 5). We also observed that
phosphorylation of a 37-kDa protein (p37) from both human nasal and
sheep tracheal epithelia was differentially modulated by nucleotides
(GTP, ATP, and GDP), [Cl
], and other anion
species (3, 4). We found that GTP was the principal phosphate donor for
p37 from both species; and in the presence of ATP/GDP, phosphorylation
of p37 was enhanced 20-fold. However, this phosphorylation could not be
inhibited by known serine/threonine and tyrosine protein kinase
inhibitors, suggesting that phosphorylation was not due to the activity
of these enzymes.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP or
[
-32P]GTP (final nucleotide concentration of 6.8 µM, without the addition of unlabeled nucleotide) in 10 mM MOPS1 (pH 7.9)
containing 5 mM dithiothreitol. The reaction was terminated by adding 5× Laemmli sample buffer (6), and the proteins were separated by SDS-12.5% polyacrylamide gel electrophoresis. Prestained molecular mass markers were used to avoid staining and destaining of
gels prior to imaging and quantification. The incorporation of
32PO4 into individual protein bands was
detected by electronic autoradiography (Canberra-Packard Instant
Imager) and quantified as described previously (3, 4).
-32P]ATP/GDP (500 nM) for
5 min at 37 °C. The reaction was terminated with 50 mM
EDTA, followed by the addition of 9 volumes of immunoprecipitation buffer (10 mM Tris-HCl (pH 7.4), 2 mM EDTA, 1 mM NaF, 1 mM dithiothreitol, 1% sodium
deoxycholate, 1% Nonidet P-40, 0.3 µM aprotinin, and 0.2 µM phenylmethylsulfonyl fluoride). The mixture was
precleared with protein G-Sepharose beads (30 min at 4 °C) and
centrifuged at 350 × g for 5 min at 4 °C, and the
supernatant was incubated with either a rabbit polyclonal or mouse
monoclonal antibody to annexin I (1 µg) for 1 h at 4 °C. New
beads were added, and the mixture was incubated overnight at 4 °C.
The incubation mixture was centrifuged at 350 × g for
5 min, and the pelleted beads were washed in 1 ml of radioimmune
precipitation assay buffer (50 mM Tris-HCl (pH 7.4), 1%
Nonidet P-40, 0.5% sodium deoxycholate, 5 mM EDTA, and 150 mM NaCl). This wash step was repeated three times, and then
50 µl of 5× sample buffer containing 100 mM
dithiothreitol was added to the pellet, left at room temperature for 30 min, and finally spun at 420 × g for 5 min. A 20-µl
aliquot was run on 12.5% polyacrylamide gels for analysis by
electronic autoradiography.
-32P]GTP or
[
-32P]ATP for 5 min at 37 °C. The reaction was
terminated with 5× Laemmli sample buffer (6). Phosphorylated protein
(10 µg) was then incubated for 10 min at 30 °C in reaction
mixtures containing phosphorylation buffer (3) alone, 0.1 N HCl (pH 1), 0.1 N NaOH (pH 13), or 0.8 M hydroxylamine and 0.1 M acetate (pH 5.2).
Phosphoramidates are stable under alkaline conditions and labile
under acidic conditions, whereas acylphosphates are labile under both
extremes. In the presence of hydroxylamine, both linkages are labile at
pH <5.5 (8). On the other hand, serine and threonine linkages are
acid-stable and base-labile, whereas tyrosine is relatively stable
under both acidic and basic conditions.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (36K):
[in a new window]
Fig. 1.
Purification and identification of p37 from
ovine epithelia as annexin I. a, shows a Coomassie
Blue-stained SDS-polyacrylamide gel of an aliquot of the original
membrane fraction (lane 1), the anion exchange flow-through
fraction (lane 2), or the lane 2 fraction
following protein concentration (lane 3). The 37-kDa protein
was excised from the gel, and peptides were obtained by tryptic digest,
purified by HPLC, and sequenced. Additionally, N-terminal sequencing
was conducted using an aliquot of the purified protein solution.
b, shows the amino acid sequences obtained. All matched the
published sequence of bovine annexin I at the amino acid
positions shown in parentheses. c,
immunoprecipitation of p37 from membranes phosphorylated with either
ATP or GTP confirmed the identity of the purified p37 protein as
annexin I. The failure to immunoprecipitate phosphorylated
-subunits
of G proteins (phosphohistidine proteins of similar size) with a G
protein
-subunit (G
Common)-specific
antibody confirmed the selectivity of annexin I phosphorylation under
these conditions.
-32P]ATP or
[
-32P]GTP. However, no phosphorylation was observed
(data not shown).
-32P]GTP or [
-32P]ATP for 5 min)
removed >95% of the radioactivity from p37 (annexin I) (data not
shown). Further analysis showed that [32P]annexin I,
phosphorylated with either [
-32P]GTP or
[
-32P]ATP, was not only acid- and hydroxylamine
acetate-labile (Fig. 2a), but
also base-stable (Fig. 2a) and inhibitable following preincubation with diethyl pyrocarbonate (data not shown). Loss of phosphate due to rapid proteolytic degradation of annexin I was
discounted because of the presence of [32P]annexin I in
control experiments lacking acid and hydroxylamine (Fig. 2a,
Buffer lane). Taken together, the above results suggested the presence of a phosphoramidate linkage on annexin I and, in particular, phosphohistidine. To confirm the identity of the
alkali-stable phosphorylated residue, an alkaline hydrolysate from
[32P]annexin I was analyzed by anion exchange
chromatography coupled with fluorescence detection. Coelution of the
32P-labeled material with derivatized
N3-phosphohistidine standard established the
presence of phosphohistidine (Fig. 2b).

View larger version (42K):
[in a new window]
Fig. 2.
Annexin I from ovine epithelia contains
phosphohistidine. a, shows electronic autoradiographs
of SDS-polyacrylamide gels of apical membrane proteins phosphorylated
with either ATP (left panel) or GTP (right panel)
for 5 min at 37 °C. Following in vitro phosphorylation,
samples were incubated for 10 min at 30 °C in the presence of 0.1 M HCl, NaOH, a mixture of acetic acid and
hydroxylamine, or a buffer control. Phosphorylation of annexin I was
acid-labile, but not alkali-labile, suggesting the presence of
N-linked phosphate, in particular, phosphohistidine.
b, shows confirmation of the presence of phosphohistidine on
annexin I by HPLC phosphoamino acid analysis (using annexin I from the
reaction mixture in the second lane in a).
The coelution of radioactivity (from annexin I phosphorylated with GTP;
boldface line) with the fluorescent phosphohistidine
(standard peak c) confirmed the presence of
[32P]phosphohistidine. No
[32P]phosphotyrosine was detected (peak d),
and both phosphoserine and phosphothreonine (peaks a and
b) are labile under the alkaline conditions used prior to
detection.
-32P]GTP for 5 min at 37 °C
and then incubated for 30 min at 30 °C in the presence of calcium (4 mM). An additional 21-kDa phosphorylated band was observed.
This result suggested cleavage of annexin I within the core domain by a
protease(s) present in the sample (Fig.
3a). Sequence analysis of
in-gel peptide digests from the 21-kDa band showed that this fragment
corresponds to the carboxyl-terminal region of annexin I most likely
covering annexin repeats 3 and 4 (Fig. 3b). The identity of
the 21-kDa fragment within the C-terminal half of the annexin core was
further confirmed using an affinity-purified polyclonal antibody (C-19,
Santa Cruz Biotechnology) raised against a peptide fragment from the
C-terminal region of annexin I. This antibody recognizes the
phosphorylated 21-kDa fragment (Fig. 3a) and thus verifies
that it is part of the C-terminal core domain of annexin I. Multiple
sequence alignments with sequences from four species showed that only
two of the three (or four depending on the species) histidine residues
(His246 and His293) within this C-terminal
domain are conserved (Fig. 3c).

View larger version (36K):
[in a new window]
Fig. 3.
Localization of phosphohistidine to the core
of annexin I. A partially purified annexin I (Anx I)
preparation pre-phosphorylated with GTP was incubated in the presence
of Ca2+ (4 mM) for 30 min at 37 °C. This
generated a phosphorylated band of 21 kDa, suggesting cleavage of
annexin I by an endogenous protease. Coomassie Blue staining showed the
presence of two protein bands (~18 and 21 kDa; not shown), only one
of which contained the phosphate label. Both bands were sequenced; and
the upper of the two, which corresponds to the
phosphorylated band, contained an amino acid sequence corresponding to
the C-terminal half of the annexin I core (b). (The sequence
of the lower band corresponds to the N terminus of the
protein (not shown).) An antibody directed against a C-terminal annexin
I peptide was used to confirm the identity of the phosphorylated band
(a). Shown are candidate histidine residues from this region
of annexin I (c; asterisks indicate histidine
residues conserved across species). Autorad, autoradiograph;
W/blot, Western blot.
-32P]ATP for 5 min at 37 °C.
Maximal inhibition of phosphorylation of annexin I by
N6-Bt-cAMP occurred at 1 mM (Fig.
4). Studies conducted to characterize the
mechanism of inhibition by cAMP showed that neither cGMP (1 mM) nor myristoylated PKA inhibitor-(14-22)-amide (4 µM) inhibited annexin I histidine phosphorylation (Fig.
4b). These results suggested that the inhibitory effect was
specific to cAMP and, unusually, independent of PKA activity.
Furthermore, no significant difference was observed between two
phosphodiesterase-resistant cAMP analogues, (Rp)- and (Sp)-cAMP-S
(100 µM) (Fig. 4b), which inhibit and activate PKA, respectively. Unexpectedly, both isomers significantly elevated annexin I phosphorylation above control levels (p < 0.05, paired t test). The increased phosphorylation was
dose-dependent, with higher isomer concentrations (1 mM) generating higher phosphate incorporation (data not
shown). This result and our observed inhibition of annexin I
phosphorylation by 5'-AMP, but not by adenine or adenosine (1 mM) (Fig. 4c), suggested that inhibition of
annexin I phosphorylation by cAMP might result from hydrolysis of the ester bond within cAMP. However, selective and nonselective inhibitors of phosphodiesterase activity (3-isobutyl-1-xanthine, Ro 20-1724, rolipram, dipyridamole, zaprinast, trequinsin, and
8-methoxymethyl-3-isobutyl-1-methylxanthine) failed to influence the
inhibitory effect of N6-Bt-cAMP (data not
shown). Consistent with the above results, the cAMP analogues
N6-2'-O-Bt2cAMP and
2'-O-Bt-cAMP, which are susceptible to phosphodiesterase activity, also failed to inhibit annexin I phosphorylation (data not
shown).

View larger version (32K):
[in a new window]
Fig. 4.
Regulation of annexin I phosphorylation.
a, an autoradiograph is presented of a membrane preparation
incubated with an increasing concentration of
N6-Bt-cAMP (N6-mbcAMP) showing
maximal inhibition of annexin I phosphorylation occurring at 1 mM (represen- tative of n = 3).
b, quantitation (mean ± S.E., n = 6) by electronic autoradiography showed that
N6-Bt-cAMP induced a 6-fold reduction in
phosphate incorporation compared with the buffer control
(p < 0.001, Student's t test). No
significant difference was found between the buffer control and PKA
peptide inhibitor (4 µM) or cGMP (1 mM). In
contrast, both (Rp)- and
(Sp)-cAMP-S (100 µM each)
significantly elevated annexin I phosphorylation (p < 0.01, Student's t test). c, AMP (but not
adenosine or adenine; 1 mM each) induced a reduction in
annexin I phosphorylation (n = 3, ±range).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-subunits in HL-60
cell membranes (16), but its cellular role remains to be established.
The work reported here identifies a previously recognized
phosphoprotein (p37) from airway epithelia as annexin I and shows that
the protein is phosphorylated on histidine residue(s) using either GTP
or ATP as phosphate donor. This represents a novel phosphorylation of
annexin I and is the first report of histidine phosphorylation of an
annexin protein. The transient nature of phosphohistidine on annexin I
and its susceptibility to hydrolysis under conditions used to detect
phosphoesters may explain why it remained undetected in previous studies.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Sarkadi, B.,
and Parker, J. C.
(1991)
Biochim. Biophys. Acta
1071,
407-427
2.
Dinudom, A.,
Young, J. A.,
and Cook, D. I.
(1993)
J. Membr. Biol.
135,
289-295
3.
Muimo, R.,
Banner, S. J.,
Marshall, L. J.,
and Mehta, A.
(1998)
Am. J. Respir. Cell Mol. Biol.
18,
270-278
4.
Treharne, K. J.,
Marshall, L. J.,
and Mehta, A.
(1994)
Am. J. Physiol.
267,
L592-L601
5.
Marshall, L. J.,
Muimo, R.,
Riemen, C. E.,
and Mehta, A.
(1999)
Am. J. Physiol.
276,
C109-C119
6.
Laemmli, U. K.
(1970)
Nature
227,
680-685
7.
Hayes, J. D.,
Kerr, L. A.,
and Cronshaw, A. D.
(1989)
Biochem. J.
264,
437-445
8.
Amster-Choder, O.,
and Wright, A.
(1997)
J. Bacteriol.
179,
5621-5624
9.
Wei, Y. F.,
and Matthews, H. R.
(1991)
Methods Enzymol.
200,
388-414
10.
Andersson, L.,
and Porath, J.
(1986)
Anal. Biochem.
154,
250-254
11.
Cohen, B. E.,
Lee, G.,
Arispe, N.,
and Pollard, H. B.
(1995)
FEBS Lett.
377,
444-450
12.
Brown, J. M.,
and Firtel, R. A
(1998)
Curr. Biol.
8,
R662-R665
13.
Maeda, T.,
Wurgler-Murphy, S. M.,
and Saito, H.
(1994)
Nature
369,
242-245
14.
Mizuno, T.
(1998)
J. Biochem. (Tokyo)
123,
555-563
15.
Crovello, C. S.,
Furie, B. C.,
and Furie, B.
(1995)
Cell
82,
279-286
16.
Wieland, T.,
Nurnberg, B.,
Ulibarri, I.,
Kaldenberg-Stasch, S.,
Schultz, G.,
and Jakobs, K. H.
(1993)
J. Biol. Chem.
268,
18111-18118
17.
Chap, H.,
Fauvel, J.,
Gassama-Diaggne, A.,
Ragab-Thomas, J.,
and Simon, M.-F.
(1991)
Med. Sci.
7,
8-9
18.
Chan, H. C.,
Kaetzel, M. A.,
Gotter, A. L.,
Dedman, J. R.,
and Nelson, D. J.
(1994)
J. Biol. Chem.
269,
32464-32468
19.
Jorgensen, A. J.,
Bennekou, P.,
Eskesen, K.,
and Kristensen, B. I.
(1997)
Pfluegers Arch. Eur. J. Physiol.
434,
261-266
20.
Kaetzel, M. A.,
Chan, H. C.,
Dubinsky, W. P.,
Dedman, J. R.,
and Nelson, D. J.
(1994)
J. Biol. Chem.
269,
5297-5302
21.
Nilius, B.,
Gerke, V.,
Prenen, J.,
Szucs, G.,
Heinke, S.,
Weber, K.,
and Droogmans, G.
(1996)
J. Biol. Chem.
271,
30631-30636
22.
Creutz, C. E.
(1992)
Science
258,
924-931
23.
Crompton, M. R.,
Moss, S. E.,
and Crumpton, M. J.
(1988)
Cell
55,
1-3
24.
Burgoyne, R. D.,
and Geisow, M. J.
(1989)
Cell Calcium
10,
1-10
25.
Raynal, P.,
and Pollard, H. B.
(1994)
Biochim. Biophys. Acta
1197,
63-93
26.
Seemann, J.,
Weber, K.,
Osborn, M.,
Parton, R. G.,
and Gerke, V.
(1996)
Mol. Biol. Cell
7,
1359-1374
27.
Rothhut, B.
(1997)
Cell Mol. Life Sci.
53,
522-526
28.
Ando, Y.,
Imamura, S.,
Owada, M. K.,
and Kannagi, R.
(1991)
J. Biol. Chem.
266,
1101-1108
29.
Seemann, J.,
Weber, K.,
and Gerke, V.
(1997)
FEBS Lett.
413,
185-190
30.
Donato, R.
(1999)
Biochim. Biophys. Acta
1450,
191-231
31.
Jost, M.,
and Gerke, V.
(1996)
Biochim. Biophys. Acta
1313,
283-289
32.
Johnstone, S. A.,
Hubaishy, I.,
and Waisman, D. M.
(1993)
Biochem. J.
294,
801-807
33.
Ando, Y.,
Imamura, S.,
Hong, Y. M.,
Owada, M. K.,
Kakunaga, T.,
and Kannagi, R.
(1989)
J. Biol. Chem.
264,
6948-6955
34.
Schlaepfer, D. D.,
and Haigler, H. T.
(1987)
J. Biol. Chem.
262,
6931-6937
35.
Regnouf, F.,
Sagot, I.,
Delouche, B.,
Devilliers, G.,
Cartaud, J.,
Henry, J. P.,
and Pradel, L. A.
(1995)
J. Biol. Chem.
270,
27143-27150
36.
Wang, W.,
and Creutz, C. E.
(1992)
Biochemistry
31,
9934-9939
37.
Varticovski, L.,
Chahwala, S. B.,
Whitman, M.,
Cantley, L.,
Schindler, D.,
Chow, E. P.,
Sinclair, L. K.,
and Pepinsky, R. B.
(1988)
Biochemistry
27,
3682-3690
38.
Weng, X.,
Luecke, H.,
Song, I. S.,
Kang, D. S.,
Kim, S. H.,
and Huber, R.
(1993)
Protein Sci.
2,
448-458
39.
Donnelly, S. R.,
and Moss, S. E.
(1997)
Cell Mol. Life Sci.
53,
533-538
40.
Gerke, V.,
and Moss, S. E.
(1997)
Biochim. Biophys. Acta
1357,
129-154
41.
Francis, S. H.,
and Corbin, J. D.
(1994)
Annu. Rev. Physiol.
56,
237-272
42.
Conti, M.,
and Jin, S. L.
(1999)
Prog. Nucleic Acids Res. Mol. Biol.
63,
1-38
43.
Corbin, J. D.,
Beebe, S. J.,
and Blackmore, P. F.
(1985)
J. Biol. Chem.
260,
8731-8735
44.
Fuhrmann, M.,
Jahn, H. U.,
Seybold, J.,
Neurohr, C.,
Barnes, P. J.,
Hippenstiel, S.,
Kraemer, H. J.,
and Suttorp, N.
(1999)
Am. J. Respir. Cell Mol. Biol.
20,
292-302
45.
Ando, Y.,
Imamura, S.,
Owada, M. K.,
Kakunaga, T.,
and Kannagi, R.
(1989)
Biochem. Cell Biol.
163,
944-951
46.
Chuah, S. Y.,
and Pallen, C. J.
(1989)
J. Biol. Chem.
264,
21160-21166
47.
Haigler, H. T.,
Schlaepfer, D. D.,
and Burgess, W. H.
(1987)
J. Biol. Chem.
262,
6921-6930
48.
Pepinsky, R. B.
(1991)
Methods Enzymol.
198,
260-272
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. A. Borthwick, J. Mcgaw, G. Conner, C. J. Taylor, V. Gerke, A. Mehta, L. Robson, and R. Muimo The Formation of the cAMP/Protein Kinase A-dependent Annexin 2 S100A10 Complex with Cystic Fibrosis Conductance Regulator Protein (CFTR) Regulates CFTR Channel Function Mol. Biol. Cell, September 1, 2007; 18(9): 3388 - 3397. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Treharne, R. M. Crawford, Z. Xu, J.-H. Chen, O. G. Best, E. A. Schulte, D. C. Gruenert, S. M. Wilson, D. N. Sheppard, K. Kunzelmann, et al. Protein Kinase CK2, Cystic Fibrosis Transmembrane Conductance Regulator, and the {Delta}F508 Mutation: F508 DELETION DISRUPTS A KINASE-BINDING SITE J. Biol. Chem., April 6, 2007; 282(14): 10804 - 10813. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Crawford, K. J. Treharne, S. Arnaud-Dabernat, J.-Y. Daniel, M. Foretz, B. Viollet, and A. Mehta Understanding the Molecular Basis of the Interaction between NDPK-A and AMPK {alpha}1 Mol. Cell. Biol., August 1, 2006; 26(15): 5921 - 5931. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dipolo and L. Beauge Sodium/Calcium Exchanger: Influence of Metabolic Regulation on Ion Carrier Interactions Physiol Rev, January 1, 2006; 86(1): 155 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J Treharne, R. M Crawford, and A Mehta CFTR, chloride concentration and cell volume: could mammalian protein histidine phosphorylation play a latent role? Exp Physiol, January 1, 2006; 91(1): 131 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bensalem, A. P. Ventura, B. Vallee, J. Lipecka, D. Tondelier, N. Davezac, A. D. Santos, M. Perretti, A. Fajac, I. Sermet-Gaudelus, et al. Down-regulation of the Anti-inflammatory Protein Annexin A1 in Cystic Fibrosis Knock-out Mice and Patients Mol. Cell. Proteomics, October 1, 2005; 4(10): 1591 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dahlin, E. M. Mager, L. Allen, Z. Tigue, L. Goodglick, M. Wadehra, and L. Dobbs Identification of Genes Differentially Expressed in Rat Alveolar Type I Cells Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cuello, R. A. Schulze, F. Heemeyer, H. E. Meyer, S. Lutz, K. H. Jakobs, F. Niroomand, and T. Wieland Activation of Heterotrimeric G Proteins by a High Energy Phosphate Transfer via Nucleoside Diphosphate Kinase (NDPK) B and Gbeta Subunits. COMPLEX FORMATION OF NDPK B WITH Gbeta gamma DIMERS AND PHOSPHORYLATION OF His-266 IN Gbeta J. Biol. Chem., February 21, 2003; 278(9): 7220 - 7226. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Hartsough, D. K. Morrison, M. Salerno, D. Palmieri, T. Ouatas, M. Mair, J. Patrick, and P. S. Steeg Nm23-H1 Metastasis Suppressor Phosphorylation of Kinase Suppressor of Ras via a Histidine Protein Kinase Pathway J. Biol. Chem., August 23, 2002; 277(35): 32389 - 32399. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gerke and S. E. Moss Annexins: From Structure to Function Physiol Rev, April 1, 2002; 82(2): 331 - 371. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |